US Stock MarketDetailed Quotes

RMD ResMed

Watchlist
  • 232.980
  • -6.500-2.71%
Close Feb 14 16:00 ET
  • 232.980
  • 0.0000.00%
Post 20:01 ET
34.22BMarket Cap27.51P/E (TTM)

ResMed Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
Total revenue
10.26%1.28B
11.08%1.22B
10.95%4.69B
9.01%1.22B
7.17%1.2B
12.48%1.16B
16.00%1.1B
18.02%4.22B
22.66%1.12B
29.20%1.12B
Operating revenue
10.26%1.28B
11.08%1.22B
10.95%4.69B
9.01%1.22B
7.17%1.2B
12.48%1.16B
16.00%1.1B
18.02%4.22B
22.66%1.12B
29.20%1.12B
Cost of revenue
2.90%530.81M
1.00%507.29M
8.71%2.03B
0.59%507.67M
1.01%504.2M
13.62%515.87M
22.66%502.26M
20.18%1.87B
28.67%504.67M
33.71%499.15M
Gross profit
16.13%751.28M
19.52%717.22M
12.72%2.66B
15.90%715.53M
12.15%692.78M
11.60%646.93M
10.96%600.06M
16.37%2.36B
18.16%617.39M
25.76%617.75M
Operating expense
8.59%334.03M
6.06%329.91M
5.61%1.27B
0.95%334.31M
0.35%318.2M
5.67%307.61M
17.35%311.06M
17.76%1.2B
24.85%331.15M
23.41%317.08M
Selling and administrative expenses
8.76%241.61M
7.23%238.98M
4.94%917.14M
0.62%242.19M
0.64%229.92M
4.95%222.16M
14.92%222.87M
18.51%874M
24.69%240.69M
25.25%228.46M
Research and development costs
10.14%81.37M
5.04%79.52M
6.91%307.53M
3.48%80.86M
0.83%77.07M
5.73%73.88M
19.82%75.71M
13.43%287.64M
21.50%78.14M
14.42%76.44M
Depreciation amortization depletion
-4.58%11.05M
-8.61%11.4M
10.71%46.52M
-8.58%11.26M
-8.07%11.2M
21.06%11.58M
56.97%12.48M
35.21%42.02M
55.88%12.32M
57.67%12.19M
-Depreciation and amortization
-4.58%11.05M
-8.61%11.4M
10.71%46.52M
-8.58%11.26M
-8.07%11.2M
21.06%11.58M
56.97%12.48M
35.21%42.02M
55.88%12.32M
57.67%12.19M
Operating profit
22.96%417.24M
34.02%387.31M
20.15%1.38B
33.18%381.22M
24.58%374.58M
17.57%339.32M
4.81%289M
14.95%1.15B
11.26%286.24M
28.35%300.67M
Net non-operating interest income expense
94.39%-775K
88.89%-1.66M
3.53%-45.71M
60.38%-5.92M
26.32%-11.03M
-33.54%-13.81M
-109.66%-14.96M
-112.35%-47.38M
-169.63%-14.94M
-173.97%-14.96M
Non-operating interest expense
----
----
-3.53%45.71M
----
----
----
----
112.35%47.38M
----
----
Total other finance cost
-94.39%775K
-88.89%1.66M
----
----
-26.32%11.03M
33.54%13.81M
109.66%14.96M
----
----
173.97%14.96M
Other net income (expense)
102.81%1.85M
-16.50%-2.15M
-2,392.04%-73.62M
-418.92%-17.56M
223.15%11.86M
-1,343.37%-66.06M
72.86%-1.85M
84.74%-2.95M
140.40%5.51M
247.79%3.67M
Gain on sale of security
23.78%-1.44M
-12.96%-680K
-140.77%-4.05M
----
----
---1.89M
---602K
181.31%9.92M
----
----
Earnings from equity interest
45.74%1.08M
124.72%963K
74.56%-1.85M
23.10%-10.56M
130.30%14.36M
-86.67%739K
26.62%-3.9M
14.39%-7.27M
-575.89%-13.73M
242.94%6.24M
Special income (charges)
--0
----
-63,692.08%-64.23M
--0
--0
-663.53%-64.23M
----
105.42%101K
596.67%9.26M
--0
-Less:Restructuring and merger&acquisition
--0
----
219.13%64.23M
--0
--0
663.53%64.23M
----
979.72%20.13M
488.47%10.97M
--0
-Less:Other special charges
----
----
----
----
----
----
----
---20.23M
----
----
Other non- operating income (expenses)
423.03%2.22M
-192.03%-2.44M
38.83%-3.49M
-4,947.54%-2.96M
2.65%-2.5M
59.81%-686K
276.06%2.65M
-278.67%-5.71M
-97.53%61K
-236.53%-2.56M
Income before tax
61.23%418.32M
40.89%383.5M
14.81%1.26B
29.24%357.73M
29.73%375.42M
-5.20%259.45M
3.97%272.19M
14.70%1.1B
16.26%276.8M
27.86%289.38M
Income tax
45.50%73.7M
36.71%72.14M
19.47%243.85M
38.95%65.5M
31.74%74.93M
3.85%50.65M
2.83%52.77M
12.74%204.11M
9.55%47.14M
20.23%56.88M
Net income
65.05%344.62M
41.90%311.36M
13.75%1.02B
27.25%292.24M
29.24%300.49M
-7.16%208.8M
4.25%219.42M
15.15%897.56M
17.74%229.66M
29.88%232.5M
Net income continuous Operations
65.05%344.62M
41.90%311.36M
13.75%1.02B
27.25%292.24M
29.24%300.49M
-7.16%208.8M
4.25%219.42M
15.15%897.56M
17.74%229.66M
29.88%232.5M
Minority interest income
Net income attributable to the parent company
65.05%344.62M
41.90%311.36M
13.75%1.02B
27.25%292.24M
29.24%300.49M
-7.16%208.8M
4.25%219.42M
15.15%897.56M
17.74%229.66M
29.88%232.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
65.05%344.62M
41.90%311.36M
13.75%1.02B
27.25%292.24M
29.24%300.49M
-7.16%208.8M
4.25%219.42M
15.15%897.56M
17.74%229.66M
29.88%232.5M
Basic earnings per share
65.49%2.35
42.28%2.12
13.40%6.94
27.56%1.99
29.11%2.04
-7.19%1.42
3.47%1.49
14.61%6.12
17.29%1.56
29.51%1.58
Diluted earnings per share
64.79%2.34
41.61%2.11
13.63%6.92
26.92%1.98
29.11%2.04
-7.19%1.42
4.20%1.49
14.91%6.09
17.29%1.56
29.51%1.58
Dividend per share
10.42%0.53
10.42%0.53
9.09%1.92
9.09%0.48
9.09%0.48
9.09%0.48
9.09%0.48
4.76%1.76
4.76%0.44
4.76%0.44
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023
Total revenue 10.26%1.28B11.08%1.22B10.95%4.69B9.01%1.22B7.17%1.2B12.48%1.16B16.00%1.1B18.02%4.22B22.66%1.12B29.20%1.12B
Operating revenue 10.26%1.28B11.08%1.22B10.95%4.69B9.01%1.22B7.17%1.2B12.48%1.16B16.00%1.1B18.02%4.22B22.66%1.12B29.20%1.12B
Cost of revenue 2.90%530.81M1.00%507.29M8.71%2.03B0.59%507.67M1.01%504.2M13.62%515.87M22.66%502.26M20.18%1.87B28.67%504.67M33.71%499.15M
Gross profit 16.13%751.28M19.52%717.22M12.72%2.66B15.90%715.53M12.15%692.78M11.60%646.93M10.96%600.06M16.37%2.36B18.16%617.39M25.76%617.75M
Operating expense 8.59%334.03M6.06%329.91M5.61%1.27B0.95%334.31M0.35%318.2M5.67%307.61M17.35%311.06M17.76%1.2B24.85%331.15M23.41%317.08M
Selling and administrative expenses 8.76%241.61M7.23%238.98M4.94%917.14M0.62%242.19M0.64%229.92M4.95%222.16M14.92%222.87M18.51%874M24.69%240.69M25.25%228.46M
Research and development costs 10.14%81.37M5.04%79.52M6.91%307.53M3.48%80.86M0.83%77.07M5.73%73.88M19.82%75.71M13.43%287.64M21.50%78.14M14.42%76.44M
Depreciation amortization depletion -4.58%11.05M-8.61%11.4M10.71%46.52M-8.58%11.26M-8.07%11.2M21.06%11.58M56.97%12.48M35.21%42.02M55.88%12.32M57.67%12.19M
-Depreciation and amortization -4.58%11.05M-8.61%11.4M10.71%46.52M-8.58%11.26M-8.07%11.2M21.06%11.58M56.97%12.48M35.21%42.02M55.88%12.32M57.67%12.19M
Operating profit 22.96%417.24M34.02%387.31M20.15%1.38B33.18%381.22M24.58%374.58M17.57%339.32M4.81%289M14.95%1.15B11.26%286.24M28.35%300.67M
Net non-operating interest income expense 94.39%-775K88.89%-1.66M3.53%-45.71M60.38%-5.92M26.32%-11.03M-33.54%-13.81M-109.66%-14.96M-112.35%-47.38M-169.63%-14.94M-173.97%-14.96M
Non-operating interest expense ---------3.53%45.71M----------------112.35%47.38M--------
Total other finance cost -94.39%775K-88.89%1.66M---------26.32%11.03M33.54%13.81M109.66%14.96M--------173.97%14.96M
Other net income (expense) 102.81%1.85M-16.50%-2.15M-2,392.04%-73.62M-418.92%-17.56M223.15%11.86M-1,343.37%-66.06M72.86%-1.85M84.74%-2.95M140.40%5.51M247.79%3.67M
Gain on sale of security 23.78%-1.44M-12.96%-680K-140.77%-4.05M-----------1.89M---602K181.31%9.92M--------
Earnings from equity interest 45.74%1.08M124.72%963K74.56%-1.85M23.10%-10.56M130.30%14.36M-86.67%739K26.62%-3.9M14.39%-7.27M-575.89%-13.73M242.94%6.24M
Special income (charges) --0-----63,692.08%-64.23M--0--0-663.53%-64.23M----105.42%101K596.67%9.26M--0
-Less:Restructuring and merger&acquisition --0----219.13%64.23M--0--0663.53%64.23M----979.72%20.13M488.47%10.97M--0
-Less:Other special charges -------------------------------20.23M--------
Other non- operating income (expenses) 423.03%2.22M-192.03%-2.44M38.83%-3.49M-4,947.54%-2.96M2.65%-2.5M59.81%-686K276.06%2.65M-278.67%-5.71M-97.53%61K-236.53%-2.56M
Income before tax 61.23%418.32M40.89%383.5M14.81%1.26B29.24%357.73M29.73%375.42M-5.20%259.45M3.97%272.19M14.70%1.1B16.26%276.8M27.86%289.38M
Income tax 45.50%73.7M36.71%72.14M19.47%243.85M38.95%65.5M31.74%74.93M3.85%50.65M2.83%52.77M12.74%204.11M9.55%47.14M20.23%56.88M
Net income 65.05%344.62M41.90%311.36M13.75%1.02B27.25%292.24M29.24%300.49M-7.16%208.8M4.25%219.42M15.15%897.56M17.74%229.66M29.88%232.5M
Net income continuous Operations 65.05%344.62M41.90%311.36M13.75%1.02B27.25%292.24M29.24%300.49M-7.16%208.8M4.25%219.42M15.15%897.56M17.74%229.66M29.88%232.5M
Minority interest income
Net income attributable to the parent company 65.05%344.62M41.90%311.36M13.75%1.02B27.25%292.24M29.24%300.49M-7.16%208.8M4.25%219.42M15.15%897.56M17.74%229.66M29.88%232.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 65.05%344.62M41.90%311.36M13.75%1.02B27.25%292.24M29.24%300.49M-7.16%208.8M4.25%219.42M15.15%897.56M17.74%229.66M29.88%232.5M
Basic earnings per share 65.49%2.3542.28%2.1213.40%6.9427.56%1.9929.11%2.04-7.19%1.423.47%1.4914.61%6.1217.29%1.5629.51%1.58
Diluted earnings per share 64.79%2.3441.61%2.1113.63%6.9226.92%1.9829.11%2.04-7.19%1.424.20%1.4914.91%6.0917.29%1.5629.51%1.58
Dividend per share 10.42%0.5310.42%0.539.09%1.929.09%0.489.09%0.489.09%0.489.09%0.484.76%1.764.76%0.444.76%0.44
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.